Table 1 Demographics and disease characteristics of the patients included in the trial
Characteristic | Overall (N = 300) | |
|---|---|---|
N | (%) | |
Median age (years), median (range) | 61 | (36–75) |
Sex | ||
Male | 263 | (88%) |
Female | 37 | (12%) |
Histologic Type | ||
Adenocarcinoma | 189 | (63%) |
Squamous cell carcinoma | 111 | (37%) |
Localization (main tumour load) | ||
Upper part (5 cm from thoracic inlet to tracheal bifurcation) | 14 | (5%) |
Lower part (tracheal bifurcation to oesophagogastric junction) | 141 | (47%) |
Oesophagogastric junction | 145 | (48%) |
Siewert Type | ||
Type I | 88 | (29%) |
Type II | 57 | (19%) |
Clinical T stage | ||
uT2 | 44 | (15%) |
uT3 | 246 | (82%) |
uT4a | 10 | (3%) |
Clinical N stage | ||
N0 | 31 | (10%) |
N+ | 269 | (90%) |
WHO Performance Status | ||
0 | 189 | (63%) |
1 | 109 | (36%) |
Missing | 2 | (1%) |